Delix Therapeutics

Biotech · Still private

Claim this profile

Follows are private to you and power your alerts

Updated · delixtherapeutics.com

Sector
Biotech
Total capital
$639K
Federal grants
$639K
2 awards · 2023
Rank in peer group#453 of 502
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
39 pending · first 2025
Rank in peer group#57 of 502

Capital timeline

2023FEDERAL ↑EQUITY ↓Cumulative $639K$319K$319K
2023FEDERAL ↑EQUITY ↓Cumulative $639K$319K$319K

Latest events

  • Federal grantHealth and Human S · Phase I · Determination of Route of Administration and Cardiac Safety of a Novel Psychoplastogen for the treatment of SUDs$319K
  • Federal grantHealth and Human S · Phase I · Determination of Route of Administration and Cardiac Safety of a Novel Psychoplastogen for the treatment of SUDs$319K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

  • Federal grantsBelow median
  • Granted patents#57 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 40
Show all 40 patent records
  • Fused Pyrrolidine Psychoplastogens And Uses ThereofJun 25, 2026 · Application 18719695Pending
  • Phenoxy And Benzyloxy Substituted Psychoplastogens And Uses ThereofJul 24, 2025 · Application 19176654Pending
  • Phenoxy And Benzyloxy Substituted Psychoplastogens And Uses ThereofMay 13, 2025 · US 12,295,959Granted
  • Constrained Amine Psychoplastogens And Uses ThereofMar 27, 2025 · Application 18719162Pending
  • Imidazopyridine Psychoplastogens And Uses ThereofFeb 20, 2025 · Application 18719684Pending
  • Aryloxy Psychoplastogens And Uses ThereofFeb 13, 2025 · Application 18719125Pending
  • Benzofuran And Benzothiophene Psychoplastogens And Uses ThereofFeb 13, 2025 · Application 18719689Pending
  • Ergoline-like Compounds For Promoting Neural PlasticitySep 21, 2023 · Application 17768725Pending
  • Tricyclic Psychoplastogens And Uses ThereofJul 20, 2023 · Application 18001190Pending
  • Isotryptamine Psychoplastogens And Uses ThereofJul 13, 2023 · Application 18001191Pending
  • Methods Of Using Phenoxy And Benzyloxy Substituted NeuroplastogensApplication 63729846Pending
  • Methods Of Treating Neuropsychiatric Disorders With Non-hallucinogenic TryptaminesApplication PCTUS2024058290Pending
  • Methods Of Using Phenoxy And Benzyloxy Substituted NeuroplastogensApplication 63699020Pending
  • Methods Of Using N-substituted Indole NeuroplastogensApplication 63699016Pending
  • Methods Of Identifying Effective Amounts Of PlastogensApplication 63698518Pending
  • Patient Specific Methods Of Treating Neuropsychiatric Disorders With Non-hallucinogenic TryptaminesApplication 63679470Pending
  • Methods Of Treating Neuropsychiatric Disorders With Non-hallucinogenic TryptaminesApplication 63679450Pending
  • Serotonin Releasing Compounds And Uses ThereofApplication PCTUS2024033644Pending
  • Fused Tetrahydroazepine Psychoplastogens And Uses ThereofApplication PCTUS2024033653Pending
  • Imidazopyridine Psychoplastogens And Uses ThereofApplication 63290033Pending
  • Methods Of Treating Neuropsychiatric Disorders With Non-hallucinogenic TryptaminesApplication 63605996Pending
  • Isotryptamine Tetracycles For Treating Brain DisordersApplication 63588936Pending
  • Fused Tetrahydroazepine Psychoplastogens And Uses ThereofApplication 63507964Pending
  • Serotonin Releasing Compounds And Uses ThereofApplication 63507952Pending
  • Imidazopyridine Psychoplastogens And Uses ThereofApplication PCTUS2022081555Pending
  • Fused Pyrrolidine Psychoplastogens And Uses ThereofApplication PCTUS2022052879Pending
  • Benzofuran And Benzothiophene Psychoplastogens And Uses ThereofApplication PCTUS2022081573Pending
  • Phenoxy And Benzyloxy Substituted Psychoplastogens And Uses ThereofApplication PCTUS2022052870Pending
  • Constrained Amine Psychoplastogens And Uses ThereofApplication PCTUS2022052888Pending
  • Phenoxy And Benzyloxy Substituted Psychoplastogens And Uses ThereofApplication 63387222Pending
  • Constrained Amine Psychoplastogens And Uses ThereofApplication 63387220Pending
  • Fused Pyrrolidine Psychoplastogens And Uses ThereofApplication 63387225Pending
  • Aryloxy Psychoplastogens And Uses ThereofApplication PCTUS2022052753Pending
  • Benzofuran And Benzothiophene Psychoplastogens And Uses ThereofApplication 63387221Pending
  • Benzofuran And Benzothiophene Psychoplastogens And Uses ThereofApplication 63290034Pending
  • Aryloxy Psychoplastogens And Uses ThereofApplication 63290026Pending
  • Fused Pyrrolidine Psychoplastogens And Uses ThereofApplication 63290037Pending
  • Aryloxy Psychoplastogens And Uses ThereofApplication 63290029Pending
  • Phenoxy And Benzyloxy Substituted Psychoplastogens And Uses ThereofApplication 63290036Pending
  • Constrained Amine Psychoplastogens And Uses ThereofApplication 63290023Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .